Gainers
- EyePoint Pharmaceuticals EYPT stock increased by 44.96% to $20.31 during Monday's pre-market session. The market value of their outstanding shares is at $584.3 million.
- Cue Biopharma CUE stock moved upwards by 20.41% to $19.94. The market value of their outstanding shares is at $633.3 million.
- Mesoblast MESO shares moved upwards by 14.67% to $7.19. The market value of their outstanding shares is at $930.9 million.
- Lexicon Pharmaceuticals LXRX shares moved upwards by 12.35% to $5.73. The company's market cap stands at $853.1 million.
- Kaleido Biosciences KLDO shares rose 11.11% to $4.7. The market value of their outstanding shares is at $200.1 million.
- Dynatronics DYNT stock rose 9.79% to $1.57. The company's market cap stands at $27.5 million. As per the news, the Q1 earnings report came out 2 days ago.
Losers
- BioXcel Therapeutics BTAI shares declined by 13.82% to $29.76 during Monday's pre-market session. The company's market cap stands at $832.6 million. The company's, Q3 earnings came out 3 days ago.
- Koninklijke Philips PHG stock declined by 10.59% to $42.58. The market value of their outstanding shares is at $38.7 billion.
- TG Therapeutics TGTX shares decreased by 8.44% to $29.1. The market value of their outstanding shares is at $4.1 billion.
- Pulmatrix PULM stock decreased by 5.95% to $0.78. The company's market cap stands at $43.9 million. As per the press release, Q3 earnings came out 3 days ago.
- Trevena TRVN stock declined by 5.25% to $0.89. The market value of their outstanding shares is at $145.7 million. The company's, Q3 earnings came out today.
- Biofrontera BFRI stock fell 4.16% to $3.23. The company's market cap stands at $37.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in